Effect of Crocin on mild to moderate maculopathy

Phase 2

Recruiting

• Conditions: Diabetic Retinopathy.; Diabetic Retinopathy; *H36.0

• Registration Number: IRCT20130418013058N13
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients with mild to moderate Maculopathy that center has not been involved
Best corrective visual acuity equal or upper than 8/10 according to Snellen chart
Diabetes mellitus with HbA1c 5.8-7 during last 3 months
No need for standard treatment including Injection, Macula Laser or Retina Laser
The absence of other serious illnesses, such as liver and kidney failure
The ability to understand the study, interventions and possible complications
The Maximum Severity of Diabetic Retinopathy be non- Proliferative Step
Blood Pressure is controlled

Exclusion Criteria

The presence of other ophthalmic conditions
Another eye disease that can affect macular edema (Retinal vein occlusion, uveitis)
Patients with anterior segmentation of the eye disorders
History of vitrectomy surgery
The presence of subfoveal hard exudates deposition
History of intraocular surgery in the last 3 months

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Central Macular Thickness. Timepoint: Before Intervention, and After Three Months. Method of measurement: Spectralis OCT Device.

Secondary Outcome Measures

Name	Time	Method
FBS Level. Timepoint: Before intervention,and three months later. Method of measurement: FBS Level Test.